Farhoud Faraji

5.3k total citations · 3 hit papers
64 papers, 2.7k citations indexed

About

Farhoud Faraji is a scholar working on Otorhinolaryngology, Surgery and Molecular Biology. According to data from OpenAlex, Farhoud Faraji has authored 64 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Otorhinolaryngology, 24 papers in Surgery and 16 papers in Molecular Biology. Recurrent topics in Farhoud Faraji's work include Head and Neck Cancer Studies (25 papers), Head and Neck Surgical Oncology (13 papers) and Salivary Gland Tumors Diagnosis and Treatment (7 papers). Farhoud Faraji is often cited by papers focused on Head and Neck Cancer Studies (25 papers), Head and Neck Surgical Oncology (13 papers) and Salivary Gland Tumors Diagnosis and Treatment (7 papers). Farhoud Faraji collaborates with scholars based in United States, Italy and United Kingdom. Farhoud Faraji's co-authors include Adam S. DeConde, Carol H. Yan, Divya P. Prajapati, Christine Boone, Carole Fakhry, Yannick Doyon, Edward J. Rebar, Jeffrey C. Miller, Fyodor D. Urnov and Philip D. Gregory and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Farhoud Faraji

61 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases

2008 681 citations Farhoud Faraji et al. profile →
Association of chemosensory dysfunction and COVID‐19 in patients presenting with influenza‐like symptoms

2020 565 citations Carol H. Yan, Farhoud Faraji et al. International Forum of Allergy & Rhinology profile →
Self‐reported olfactory loss associates with outpatient clinical course in COVID‐19

2020 242 citations Carol H. Yan, Farhoud Faraji et al. International Forum of Allergy & Rhinology profile →

Peers

Countries citing papers authored by Farhoud Faraji

Since Specialization

Citations

This map shows the geographic impact of Farhoud Faraji's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Farhoud Faraji with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Farhoud Faraji more than expected).

Fields of papers citing papers by Farhoud Faraji

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Farhoud Faraji. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Farhoud Faraji. The network helps show where Farhoud Faraji may publish in the future.

Co-authorship network of co-authors of Farhoud Faraji

This figure shows the co-authorship network connecting the top 25 collaborators of Farhoud Faraji. A scholar is included among the top collaborators of Farhoud Faraji based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Farhoud Faraji. Farhoud Faraji is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular patterns and mechanisms of tumorigenesis in HPV-associated and HPV-independent sinonasal squamous cell carcinoma 2025 ·Nature Communications ·(unknown), Sreenivasulu Gunti, Gabriel J. Starrett, Farhoud Faraji, (unknown), Anirudh Saraswathula, Kenny Vu, Anuj Gupta, Yan Zhang, Daniel L. Faden, Michael Bryan, Theresa Guo, Nicholas R. Rowan, Murugappan Ramanathan, Andrew P. Lane, Carole Fakhry, Gary L. Gallia, Clint Allen, Lisa M. Rooper, Nyall R. London	0
2	Transoral Surgery in HPV‐Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System 2023 ·The Laryngoscope ·Farhoud Faraji, Abhishek Kumar, (unknown), (unknown), Daniel Cherry, P.T. Courtney, Andrey Finegersh, Theresa Guo, Ezra E.W. Cohen, Joseph A. Califano, Loren K. Mell, Brent S. Rose, Ryan K. Orosco	1
3	Simulation‐based workshop for emergency preparedness in otolaryngology 2023 ·Laryngoscope Investigative Otolaryngology ·(unknown), (unknown), (unknown), Robert Saddawi‐Konefka, Jeffrey P. Harris, Charles S. Coffey, Ryan K. Orosco, Deborah Watson, (unknown), Farhoud Faraji, David B. Hom	2
4	Adjuvant Radiotherapy in Surgically Treated HPV-Positive Oropharyngeal Carcinoma with Adverse Pathological Features 2022 ·Cancers ·(unknown), Farhoud Faraji, John Pang, Loren K. Mell, Joseph A. Califano, Ryan K. Orosco	4
5	Trends in Positive Surgical Margins in cT1‐T2 Oral Cavity Squamous Cell Carcinoma 2022 ·The Laryngoscope ·Emily Robinson, (unknown), Isaac H. Solomon, Jacob S. Brady, John Pang, Farhoud Faraji, Jeffrey Houlton, Neal D. Futran, Brittany Barber	9
6	Bamlanivimab therapy for acute COVID-19 does not blunt SARS-CoV-2–specific memory T cell responses 2022 ·JCI Insight ·Sydney I. Ramirez, Alba Grifoni, Daniela Weiskopf, Urvi M. Parikh, Amy Heaps, Farhoud Faraji, Scott F. Sieg, Justin Ritz, Carlee Moser, Joseph J. Eron, Judith S. Currier, Paul Klekotka, Alessandro Sette, David A. Wohl, Eric S. Daar, Michael D. Hughes, Kara W Chew, Davey M. Smith, Shane Crotty	5
7	Genomic Hippo Pathway Alterations and Persistent YAP/TAZ Activation: New Hallmarks in Head and Neck Cancer 2022 ·Cells ·Farhoud Faraji, Sydney I. Ramirez, (unknown), (unknown), J. Silvio Gutkind	25
8	High rates of postoperative radiotherapy delay in head and neck cancer before and after Medicaid expansion 2021 ·Head & Neck ·John Pang, Farhoud Faraji, (unknown), Loren K. Mell, Jeffrey Houlton, Joseph A. Califano	6
9	Robotic surgery may improve overall survival for T1 and T2 tumors of the hypopharynx: An NCDB cohort study 2021 ·Oral Oncology ·Andrey Finegersh, (unknown), Bharat Panuganti, Farhoud Faraji, F. Christopher Holsinger, Kevin T. Brumund, Charles S. Coffey, Joseph A. Califano, Ryan K. Orosco	7
10	Association of chemosensory dysfunction and COVID‐19 in patients presenting with influenza‐like symptoms breakdown → 2020 ·International Forum of Allergy & Rhinology ·Carol H. Yan, Farhoud Faraji, Divya P. Prajapati, Christine Boone, Adam S. DeConde	565
11	Electric scooter craniofacial trauma 2020 ·Laryngoscope Investigative Otolaryngology ·Farhoud Faraji, Jason H. Lee, Farshid Faraji, Bridget V. MacDonald, (unknown), (unknown), (unknown), (unknown), Samuel Lance, Amanda A. Gosman, Edward M. Castillo, David B. Hom	48
12	Does Subglottic Squamous Cell Carcinoma Warrant a Different Strategy Than Other Laryngeal Subsites? 2020 ·The Laryngoscope ·(unknown), (unknown), Matthew C. Gropler, Farhoud Faraji, Gregory M. Ward	3
13	Computed tomography performance in predicting extranodal extension in HPV‐positive oropharynx cancer 2019 ·The Laryngoscope ·Farhoud Faraji, Nafi Aygün, Stephanie Coquia, Christine G. Gourin, Marietta Tan, Lisa M. Rooper, David W. Eisele, Carole Fakhry	28
14	Prognostic significance of surgical margins after transoral laser microsurgery for early-stage glottic squamous cell carcinoma 2019 ·Oral Oncology ·(unknown), Farhoud Faraji, Nosayaba Osazuwa‐Peters, Ronald J. Walker, Gregory M. Ward	20
15	Priorities of human papillomavirus-associated oropharyngeal cancer patients at diagnosis and after treatment 2019 ·Oral Oncology ·Melina J. Windon, Carole Fakhry, Farhoud Faraji, Tanya Troy, Christine G. Gourin, Ana P. Kiess, Wayne M. Koch, David W. Eisele, Gypsyamber DʼSouza	19
16	Tumor‐infiltrating lymphocyte quantification stratifies early‐stage human papillomavirus oropharynx cancer prognosis 2019 ·The Laryngoscope ·Farhoud Faraji, Nicholas Fung, (unknown), Christine G. Gourin, David W. Eisele, Lisa M. Rooper, Carole Fakhry	29
17	Reader performance in the ultrasonographic evaluation of oropharyngeal carcinoma 2018 ·Oral Oncology ·Farhoud Faraji, (unknown), (unknown), (unknown), Ray Blanco, Satomi Kawamoto, Sheila Sheth, Ulrike M. Hamper, Carole Fakhry	5
18	Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database 2018 ·Oral Oncology ·Eleni M. Rettig, (unknown), Farhoud Faraji, David W. Eisele, Margueritta El Asmar, Nicholas Fung, Gypsyamber DʼSouza, Carole Fakhry	66
19	Evaluating oropharyngeal carcinoma with transcervical ultrasound, CT, and MRI 2018 ·Oral Oncology ·Farhoud Faraji, Stephanie Coquia, (unknown), (unknown), (unknown), M. Robert DeJong, Nafi Aygün, Ulrike M. Hamper, Carole Fakhry	16
20	Molecular mechanisms of human papillomavirus-related carcinogenesis in head and neck cancer 2017 ·Microbes and Infection ·Farhoud Faraji, (unknown), Carole Fakhry, Daria A. Gaykalova	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact